Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:42 PM
Ignite Modification Date:
2025-12-24 @ 5:42 PM
NCT ID:
NCT04525768
Eligibility Criteria:
Inclusion Criteria:
* male or female patients aged 18-75
* diagnosed as portal hypertension and portal cavernoma by contrast-enhanced computed tomography
* underwent JAK2 mutation test
Exclusion Criteria:
* combined known etiologies of chronic liver disease, including hepatitis, primary biliary cirrhosis, schistosomiasis, and non-alcoholic fatty liver disease.
* other factors judged by the investigator that may affect the safety of the subject or the compliance of the trial. Such as serious illnesses (including mental illness) that require combined treatment, serious laboratory abnormalities, or other family or social factors.
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT04525768
Study Brief:
Protocol Section:
NCT04525768